RoundTable's Renaissance sells topical drug division to Mylan

Renaissance Acquisition Holdings, LLC, a portfolio company of RoundTable Healthcare Partners, agreed to sell its topical pharmaceutical division to Mylan N.V. for $950 million in cash at closing. Additional contingency payments could total $50 million. Mylan is a global generic and specialty pharmaceutical company. Private equity firm RoundTable focuses exclusively on the health-care industry and started Renaissance in 2010 following a pair of acquisitions.

DealsNorth AmericaUSBriefs